FMX Stock Analysis: Fomento Economico Mexicano | NYSE
Beverages - Brewers | NYSE, USA | Market Cap: 39.853m USD | 12M Return: 41% | US3444191064 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 52.4M
EPS Trend: -27.5%
Qual. Beats: 0
Rev. Trend: -89.2%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Fomento Económico Mexicano (FEMSA), traded on the NYSE under the ticker FMX, is a Mexican multinational founded in 1890 and headquartered in Monterrey, Mexico. It operates as a major franchise bottler of Coca-Cola trademark beverages across Latin America, producing, marketing, and distributing brands in countries including Mexico, Guatemala, Colombia, Brazil, and Argentina. The company is organized into segments such as Coca-Cola FEMSA, Proximity Americas, Proximity Europe, and Health, among others.
Beyond beverages, FEMSA runs a large small-box retail chain under the OXXO brand in Mexico, Colombia, Peru, Chile, Brazil, and the United States, along with OXXO GAS service stations in Mexico. It also operates drugstores in Chile, Colombia, Ecuador, and Mexico under brands such as Cruz Verde and Fybeca, while its European proximity division manages small-box retail and foodvenience concepts like k kiosk, BackWerk, and avec in Switzerland, Germany, Austria, Luxembourg, and the Netherlands. Additional businesses include fuel retail, transport logistics, electronic payment processing for small and medium-sized businesses (Spin), and the Bara discount grocery banner. As a constituent of the GICS Consumer Staples sector, FEMSAs operations span bottling, convenience retail, fuel, and pharmacy verticals.
- OXXO same-store sales and store count expansion lift Mexico revenue
- Mexican peso weakness pressures USD-translated bottling margins
- Coca-Cola FEMSA Latin America pricing offsets volume softness
| Net Income: 1.74b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 8.79 > 1.0 |
| NWC/Revenue: 3.86% < 20% (prev 1.90%; Δ 1.95% < -1%) |
| CFO/TA 0.13 > 3% & CFO 5.74b > Net Income 1.74b |
| Net Debt (123b) to EBITDA (25.2b): 4.90 < 3 |
| Current Ratio: 1.14 > 1.5 & < 3 |
| Outstanding Shares: last quarter (341.3m) vs 12m ago -1.65% < -2% |
| Gross Margin: 40.50% > 18% (prev 40.50%; Δ 0.01% > 0.5%) |
| Asset Turnover: 107.6% > 50% (prev 517.4%; Δ -409.8% > 0%) |
| Interest Coverage Ratio: 21.46 > 6 (EBIT TTM 22.7b / Interest Expense TTM 1.06b) |
| A: 0.04 (Total Current Assets 15.6b - Total Current Liabilities 13.7b) / Total Assets 45.9b |
| B: 0.32 (Retained Earnings 14.8b / Total Assets 45.9b) |
| C: 0.51 (EBIT TTM 22.7b / Avg Total Assets 45.0b) |
| D: 0.43 (Book Value of Equity 12.4b / Total Liabilities 28.7b) |
| Altman-Z'' = 5.17 = AAA |
| DSRI: 3.0 (Receivables 45.3b/3.73b, Revenue 48.4b/228b) |
| GMI: 1.00 (GM 40.50% / 40.50%) |
| AQI: -21.20 (AQ_t -5.77 / AQ_t-1 0.27) |
| SGI: 0.21 (Revenue 48.4b / 228b) |
| TATA: -0.09 (NI 1.74b - CFO 5.74b) / TA 45.9b) |
| Beneish M = -15.12 (Cap -4..+1) = AAA |
As of October 13, 2026, the stock is trading at USD 121.65 with a total of 357,180 shares traded. Over the past week, the price has changed by +4.05%, over one month by +0.32%, over three months by -4.39% and over the past year by +41.01%.
Current recommended Stop Loss: 118.10 (which is 2.9% or 1.3 ATR below the current price).
Fomento Economico Mexicano has received a consensus analysts rating of 3.73. Therefore, it is recommended to hold FMX.
- StrongBuy: 5
- Buy: 2
- Hold: 7
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 134.1 | 10.3% |
P/E Trailing = 8.3082
P/E Forward = 89.2857
P/S = 0.0457
P/B = 3.2432
P/EG = 4.7275
Revenue TTM = 48.4b USD
EBIT TTM = 22.7b USD
EBITDA TTM = 25.2b USD
Long Term Debt = 125b USD (from longTermDebt, last quarter)
Short Term Debt = 1.74b USD (from shortTermDebt, last quarter)
Debt = 240b USD (corrected: LT Debt 125b + ST Debt 1.74b) + Leases 113b
Net Debt = 123b USD (calculated: Debt 240b - CCE 117b)
Enterprise Value = 163b USD (39.9b + Debt 240b - CCE 117b)
Interest Coverage Ratio = 21.46 (Ebit TTM 22.7b / Interest Expense TTM 1.06b)
EV/FCF = 46.44x (Enterprise Value 163b / FCF TTM 3.51b)
FCF Yield = 2.15% (FCF TTM 3.51b / Enterprise Value 163b)
FCF Margin = 7.26% (FCF TTM 3.51b / Revenue TTM 48.4b)
Net Margin = 3.60% (Net Income TTM 1.74b / Revenue TTM 48.4b)
Gross Margin = 40.50% ((Revenue TTM 48.4b - Cost of Revenue TTM 28.8b) / Revenue TTM)
Gross Margin QoQ = 40.09% (prev 40.47%)
Tobins Q-Ratio = 3.55 (Enterprise Value 163b / Total Assets 45.9b)
Interest Expense / Debt = 0.44% (Interest Expense 1.06b / Debt 240b)
Taxrate = 29.46% (1.07b / 3.64b)
NOPAT = 16.0b (EBIT 22.7b * (1 - 29.46%))
Current Ratio = 1.14 (Total Current Assets 15.6b / Total Current Liabilities 13.7b)
Debt / Equity = 19.35 (Debt 240b / totalStockholderEquity, last quarter 12.4b)
Debt / EBITDA = 4.90 (Net Debt 123b / EBITDA 25.2b)
Debt / FCF = 35.09 (Net Debt 123b / FCF TTM 3.51b)
Total Stockholder Equity = 12.8b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.87% (Net Income 1.74b / Total Assets 45.9b)
RoE = 13.61% (Net Income TTM 1.74b / Total Stockholder Equity 12.8b)
RoCE = 16.51% (EBIT 22.7b / Capital Employed (Equity 12.8b + L.T.Debt 125b))
RoIC = 50.81% (NOPAT 16.0b / Invested Capital 31.5b)
WACC = 1.29% (E(39.9b)/V(280b) * Re(7.19%) + D(240b)/V(280b) * Rd(0.44%) * (1-Tc(0.29)))
Discount Rate = 7.19% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -85.11 | Cagr: -51.72%
[DCF] Terminal Value 75.44% ; FCFF base≈3.51b ; Y1≈3.53b ; Y5≈3.74b
[DCF] Fair Price = N/A (negative equity: EV 58.1b - Net Debt 123b = -65.1b; debt exceeds intrinsic value)
EPS Correlation: -27.51 | EPS CAGR: -9.05% | SUE: 0.03 | # QB: 0
Revenue Correlation: -89.24 | Revenue CAGR: -72.00% | SUE: -0.59 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.99 | Chg30d=-5.36% | Revisions=+0% | Analysts=3
EPS current Year (2026-12-31): EPS=5.47 | Chg30d=-8.89% | Revisions=+25% | GrowthEPS=+91.3% | GrowthRev=+7.1%
EPS next Year (2027-12-31): EPS=5.18 | Chg30d=-0.30% | Revisions=+40% | GrowthEPS=-5.2% | GrowthRev=+7.9%
[Analyst] Revisions Ratio: +38% (up=4, down=1)